Remove Bioinformatics Remove Drug Delivery Remove Genetic Engineering Remove Production
article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Sebastian Jaeger, PhD, Senior Scientist, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA, on: ‘Evaluation of Fcab-drug conjugates as a novel antibody-based format for targeted drug delivery’. Marketing Product Manager, Product, NanoTemper Technologies.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Lei Shi, PhD, Senior Vice President, R&D, Biointron Biological, on: ‘Accelerating early discovery through htp and high-speed antibody production’. Paul Dyer, PhD, Field Application Scientist, Halo Labs, on: ‘Total particle analysis with aura; pathway to USP validation and product release’.